Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Download PDF
  • Retraction Note
  • Open access
  • Published:

Retraction Note: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes

Diabetology & Metabolic Syndrome volume 17, Article number: 21 (2025) Cite this article

The Original Article was published on 25 June 2024

Retraction Note: Diabetology & Metabolic Syndrome (2024) 16:140

https://doi.org/10.1186/s13098-024-01369-x

The Editors-in-Chief have retracted this article because it shows significant overlap with an unpublished manuscript under review at another journal. Jianbin Guan, Haimiti Abudouaini and Kaitan Yang agree with this retraction. Kaiyuan Lin has not responded to correspondence from the Publisher about this retraction.

Author information

Authors and Affiliations

  1. Honghui-Hospital, Xi’an Jiaotong University, Xi’an, 710054, Shaanxi, China

    Jianbin Guan, Haimiti Abudouaini, Kaiyuan Lin & Kaitan Yang

  2. Truma Rehabilitation Department, Honghui-Hospital, Xi’an Jiaotong University, Xi’an, 710054, Shaanxi, China

    Kaitan Yang

Authors
  1. Jianbin Guan
    View author publications

    Search author on:PubMed Google Scholar

  2. Haimiti Abudouaini
    View author publications

    Search author on:PubMed Google Scholar

  3. Kaiyuan Lin
    View author publications

    Search author on:PubMed Google Scholar

  4. Kaitan Yang
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Kaiyuan Lin or Kaitan Yang.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13098-024-01369-x.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guan, J., Abudouaini, H., Lin, K. et al. Retraction Note: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes. Diabetol Metab Syndr 17, 21 (2025). https://doi.org/10.1186/s13098-025-01596-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13098-025-01596-w

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us